Background: Regular exercise and consuming long-chain n−3 fatty acids (FAs) from fish or fish oil can independently improve cardiovascular and metabolic health, but combining these lifestyle modifications may be more effective than either treatment alone. Objective: We examined the individual and combined effects of n−3 FA supplements and regular exercise on body composition and cardiovascular health. Design: Overweight volunteers [body mass index (BMI; in kg/m2): >25] with high blood pressure, cholesterol, or triacylglycerols were randomly assigned to one of the following interventions: fish oil (FO), FO and exercise (FOX), sunflower oil (SO; control), or SO and exercise (SOX). Subjects consumed 6 g tuna FO/d (≈1.9 g n−3 FA) or 6 g SO/d. The exercise groups walked 3 d/wk for 45 min at 75% age-predicted maximal heart rate. Plasma lipids, blood pressure, and arterial function were assessed at 0, 6, and 12 wk. Body composition was assessed by dual-energy X-ray absorptiometry at 0 and 12 wk only. Results: FO supplementation lowered triacylglycerols, increased HDL cholesterol, and improved endothelium-dependent arterial vasodilation (P < 0.05). Exercise improved arterial compliance (P < 0.05). Both fish oil and exercise independently reduced body fat (P < 0.05). Conclusions: FO supplements and regular exercise both reduce body fat and improve cardiovascular and metabolic health. Increasing intake of n−3 FAs could be a useful adjunct to exercise programs aimed at improving body composition and decreasing cardiovascular disease risk.
1 January 2006 in International Journal of Behavioral Nutrition and Physical Activity
Self-report recall questionnaires are commonly used to measure physical activity, energy expenditure and time use in children and adolescents. However, self-report questionnaires show low to moderate validity, mainly due to inaccuracies in recalling activity in terms of duration and intensity. Aside from recall errors, inaccuracies in estimating energy expenditure from self-report questionnaires are compounded by a lack of data on the energy cost of everyday activities in children and adolescents. This article describes the development of the Multimedia Activity Recall for Children and Adolescents (MARCA), a computer-delivered use-of-time instrument designed to address both the limitations of self-report recall questionnaires in children, and the lack of energy cost data in children. The test-retest reliability of the MARCA was assessed using a sample of 32 children (aged 11.8 ± 0.7 y) who undertook the MARCA twice within 24-h. Criterion validity was assessed by comparing self-reports with accelerometer counts collected on a sample of 66 children (aged 11.6 ± 0.8 y). Content and construct validity were assessed by establishing whether data collected using the MARCA on 1429 children (aged 11.9 ± 0.8 y) exhibited relationships and trends in children's physical activity consistent with established findings from a number of previous research studies. Test-retest reliability was high with intra-class coefficients ranging from 0.88 to 0.94. The MARCA demonstrated criterion validity comparable to other self-report instruments with Spearman coefficients ranging from rho = 0.36 to 0.45, and provided evidence of good content and construct validity. The MARCA is a valid and reliable self-report questionnaire, capable of a wide variety of flexible use-of-time analyses related to both physical activity and sedentary behaviour, and offers advantages over existing pen-and-paper questionnaires.
1 January 2012 in The American Journal of Clinical Nutrition
Anthocyanins are of interest due to their anti-oxidative and vasodilatory properties. Earlier reviews have shown that berries and other anthocyanin rich foods or extracts can improve vascular health, however the effect of anthocyanins on vascular function has not yet been reviewed. To address this gap in the literature, we conducted a systematic review and meta-analysis of randomised-controlled trials examining anthocyanin-rich foods or extracts on measures of vascular reactivity and/or stiffness in adults. Data from 24 studies were pooled as standardized mean difference (SMD) with 95% confidence intervals (CI). Anthocyanin consumption significantly improved flow-mediated dilation (FMD) following acute (SMD: 3.92%, 95% CI: 1.47, 6.38, p = 0.002; I2 = 91.8%) and chronic supplementation (SMD: 0.84%, 95% CI: 0.55, 1.12, p = 0.000; I2 = 62.5%). Pulse wave velocity was improved following acute supplementation only (SMD: −1.27 m/s, 95% CI: −1.96, −0.58, p = 0.000; I2 = 17.8%). These results support the findings of previous reviews that anthocyanin rich foods or extracts may indeed improve vascular health, particularly with respect to vascular reactivity measured by FMD. More research is required to determine the optimal dosage, and the long-term effects of consumption.
Covering: Mid-2000 to 2002. Previous reviews: Nat. Prod. Rep., 2001, 18, 231–281; Nat. Prod. Rep., 2001, 18, 190–227. This review covers the biosynthesis of aliphatic and aromatic polyketides as well as mixed polyketide/NRPS metabolites, and discusses the molecular genetics and enzymology of the proteins responsible for their formation.
5 January 2015 in Journal of the American Heart Association
Background: Avocados are a nutrient‐dense source of monounsaturated fatty acids ( MUFA ) that can be used to replace saturated fatty acids ( SFA ) in a diet to lower low density lipoprotein cholesterol ( LDL ‐C). Well‐controlled studies are lacking on the effect of avocado consumption on cardiovascular disease ( CVD ) risk factors. Methods and Results: A randomized, crossover, controlled feeding trial was conducted with 45 overweight or obese participants with baseline LDL‐C in the 25th to 90th percentile. Three cholesterol‐lowering diets (6% to 7% SFA) were fed (5 weeks each): a lower‐fat diet (LF: 24% fat); 2 moderate‐fat diets (34% fat) provided similar foods and were matched for macronutrients and fatty acids: the avocado diet (AV) included one fresh Hass avocado (136 g) per day, and the moderate‐fat diet (MF) mainly used high oleic acid oils to match the fatty acid content of one avocado. Compared with baseline, the reduction in LDL‐C and non‐high‐density lipoprotein (HDL) cholesterol on the AV diet (−13.5 mg/ dL , −14.6 mg/ dL ) was greater ( P <0.05) than the MF (−8.3 mg/ dL , −8.7 mg/ dL ) and LF (−7.4 mg/ dL , −4.8 mg/ dL ) diets. Furthermore, only the AV diet significantly decreased LDL particle number (LDL‐P, −80.1 nmol/L, P =0.0001), small dense LDL cholesterol (LDL 3+4 , −4.1 mg/ dL , P =0.04), and the ratio of LDL/HDL (−6.6%, P <0.0001) from baseline. Conclusions: Inclusion of one avocado per day as part of a moderate‐fat, cholesterol‐lowering diet has additional LDL ‐C, LDL ‐P, and non‐ HDL ‐C lowering effects, especially for small, dense LDL . Our results demonstrate that avocados have beneficial effects on cardio‐metabolic risk factors that extend beyond their heart‐healthy fatty acid profile. Clinical Trial Registration: URL: http://www.clinicaltrials.gov . Unique identifier: NCT01235832.